PRECISION BIOSCIENCES INC (DTIL) — insider trading
Health Care · NASDAQ
PRECISION BIOSCIENCES INC (DTIL) has 15 reported SEC Form 4 insider transactions in our data (latest 2026-06-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Buehler Kevin | Director | Grant / award / vesting (derivative) | 20,979 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Pire Shari Lisa | Director | Grant / award / vesting (derivative) | 20,979 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Germano Geno J | Director | Grant / award / vesting (derivative) | 20,979 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Frankel Stanley | Director | Grant / award / vesting (derivative) | 20,979 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Brown Melinda | Director | Grant / award / vesting (derivative) | 20,979 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Amoroso Michael | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 573,888 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Kelly John Alexander | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 193,688 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Scimeca Dario | Officer (General Counsel and Secretary) | Grant / award / vesting (derivative) | 107,604 | $0.00 | $0 | Form 4 |
| 2026-06-01 | SMITH J. JEFFERSON | Officer (Chief Research Officer) | Grant / award / vesting (derivative) | 57,389 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Brown Melinda | Director | Option exercise / conversion (derivative) | 21,000 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Brown Melinda | Director | Option exercise / conversion | 21,000 | — | — | Form 4 |
| 2026-05-20 | Frankel Stanley | Director | Option exercise / conversion (derivative) | 21,000 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Frankel Stanley | Director | Option exercise / conversion | 21,000 | — | — | Form 4 |
| 2026-05-20 | Buehler Kevin | Director | Option exercise / conversion (derivative) | 21,000 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Buehler Kevin | Director | Option exercise / conversion | 21,000 | — | — | Form 4 |
Ask the chat about DTIL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PRECISION BIOSCIENCES INC (DTIL).
Last updated 2026-06-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.